Category: Headlines in Dermatology

Fall Clinical News: Deuruxolitinib Shows Early and Sustained Efficacy in AA

New research adds to a growing body of evidence supporting the safety and efficacy of deuruxolitinib (Leqselvi, Sun Pharma) in alopecia areata (AA).